Ning-Ai Liu

Trials

Studies that name Ning-Ai Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:58 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT03774446 · Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  Cedars-Sinai Medical Center · completed · Cushing Disease · study director
• Ph2
  NCT02780882 · SOM230 Ectopic ACTH-producing Tumors

  Cedars-Sinai Medical Center · withdrawn · Ectopic ACTH Syndrome · principal investigator
• Ph2
  NCT02160730 · Treatment of Cushing's Disease With R-roscovitine

  Shlomo Melmed, MD · terminated · Cushings Disease · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Genetics of Pituitary Development in Zebrafish
  R03DK075757 · NIDDK · CEDARS-SINAI MEDICAL CENTER · fiscal years 2007 to 2008 · $77,910 awarded in 2008
  Same name and institution; not confirmed by an ID
• Genetics of Corticotroph Development in Zebrafish
  K08DK064806 · NIDDK · CEDARS-SINAI MEDICAL CENTER · fiscal years 2003 to 2007 · $123,552 awarded in 2007
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovit
  R21DK103198 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI SHLOMO MELMED · fiscal years 2014 to 2015
  Named on NCT02160730